share_log

Aravive Analyst Ratings

Aravive Analyst Ratings

Aravive 分析師評級
Benzinga ·  2023/07/21 08:50
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/21/2023 922.73% Cantor Fitzgerald → $18 Reiterates Overweight → Overweight
07/17/2023 922.73% Cantor Fitzgerald → $18 Reiterates Overweight → Overweight
07/10/2023 922.73% Cantor Fitzgerald → $18 Reiterates Overweight → Overweight
07/03/2023 922.73% Cantor Fitzgerald $18 → $18 Reiterates Overweight → Overweight
06/05/2023 581.82% HC Wainwright & Co. → $12 Reiterates Buy → Buy
06/05/2023 468.18% EF Hutton → $10 Reiterates Buy → Buy
05/26/2023 468.18% EF Hutton → $10 Reiterates Buy → Buy
05/26/2023 581.82% HC Wainwright & Co. → $12 Reiterates Buy → Buy
05/25/2023 468.18% EF Hutton → $10 Reiterates Buy → Buy
05/25/2023 581.82% HC Wainwright & Co. → $12 Reiterates Buy → Buy
05/17/2023 922.73% Cantor Fitzgerald → $18 Reiterates Overweight → Overweight
05/11/2023 468.18% EF Hutton → $10 Reiterates Buy → Buy
05/11/2023 581.82% HC Wainwright & Co. → $12 Reiterates Buy → Buy
03/16/2023 581.82% HC Wainwright & Co. $7 → $12 Maintains Buy
02/21/2023 297.73% HC Wainwright & Co. → $7 Reiterates → Buy
02/14/2023 468.18% EF Hutton → $10 Maintains Buy
01/05/2023 468.18% EF Hutton → $10 Initiates Coverage On → Buy
11/14/2022 13.64% Piper Sandler $6 → $2 Maintains Overweight
10/25/2022 297.73% HC Wainwright & Co. $26 → $7 Maintains Buy
06/03/2022 752.27% Roth Capital → $15 Initiates Coverage On → Buy
03/08/2021 1377.27% BTIG → $26 Initiates Coverage On → Buy
09/18/2020 — William Blair Initiates Coverage On → Outperform
07/23/2020 1377.27% HC Wainwright & Co. $15 → $26 Maintains Buy
03/27/2020 752.27% HC Wainwright & Co. $25 → $15 Maintains Buy
12/20/2019 1320.45% HC Wainwright & Co. $31 → $25 Maintains Buy
12/10/2019 1604.55% Cantor Fitzgerald → $30 Initiates Coverage On → Overweight
11/20/2019 1661.36% HC Wainwright & Co. $18 → $31 Reiterates → Buy
11/19/2019 1945.45% Piper Sandler $15 → $36 Maintains Overweight
10/10/2019 922.73% HC Wainwright & Co. → $18 Initiates Coverage On → Buy
05/13/2019 468.18% Piper Sandler → $10 Initiates Coverage On → Overweight
04/09/2019 695.45% Wedbush → $14 Initiates Coverage On → Outperform
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
07/21/2023 922.73% 康託·菲茨傑拉德 →$18 重申 超重→超重
07/17/2023 922.73% 康託·菲茨傑拉德 →$18 重申 超重→超重
07/10/2023 922.73% 康託·菲茨傑拉德 →$18 重申 超重→超重
07/03/2023 922.73% 康託·菲茨傑拉德 $18→$18 重申 超重→超重
06/05/2023 581.82% HC Wainwright公司 →$12 重申 購買→購買
06/05/2023 468.18% EF Hutton →$10 重申 購買→購買
2023年05月26日 468.18% EF Hutton →$10 重申 購買→購買
2023年05月26日 581.82% HC Wainwright公司 →$12 重申 購買→購買
2023年05月25日 468.18% EF Hutton →$10 重申 購買→購買
2023年05月25日 581.82% HC Wainwright公司 →$12 重申 購買→購買
2023年05月17日 922.73% 康託·菲茨傑拉德 →$18 重申 超重→超重
2023年05月11日 468.18% EF Hutton →$10 重申 購買→購買
2023年05月11日 581.82% HC Wainwright公司 →$12 重申 購買→購買
03/16/2023 581.82% HC Wainwright公司 $7→$12 維護 買
02/21/2023 297.73% HC Wainwright公司 →$7 重申 →購買
02/14/2023 468.18% EF Hutton →$10 維護 買
01/05/2023 468.18% EF Hutton →$10 開始承保 →購買
2022年11月14日 13.64% 派珀·桑德勒 $6→$2 維護 超重
2022年10月25日 297.73% HC Wainwright公司 $26→$7 維護 買
06/03/2022 752.27% 羅斯資本 →$15 開始承保 →購買
03/08/2021 1377.27% BTIG →$26 開始承保 →購買
09/18/2020 - 威廉·布萊爾 開始承保 →跑贏大盤
07/23/2020 1377.27% HC Wainwright公司 $15→$26 維護 買
03/27/2020 752.27% HC Wainwright公司 $25→$15 維護 買
2019年12月20日 1320.45% HC Wainwright公司 $31→$25 維護 買
2019年12月10日 1604.55% 康託·菲茨傑拉德 →$30 開始承保 →超重
2019年11月20日 1661.36% HC Wainwright公司 $18→$31 重申 →購買
2019年11月19日 1945.45% 派珀·桑德勒 $15→$36 維護 超重
2019年10月10日 922.73% HC Wainwright公司 →$18 開始承保 →購買
2019年05月13日 468.18% 派珀·桑德勒 →$10 開始承保 →超重
2019年09月04日 695.45% 韋德布什 →$14 開始承保 →跑贏大盤

What is the target price for Aravive (ARAV)?

Aravive(ARAV)的目標價是多少？

The latest price target for Aravive (NASDAQ: ARAV) was reported by Cantor Fitzgerald on July 21, 2023. The analyst firm set a price target for $18.00 expecting ARAV to rise to within 12 months (a possible 922.73% upside). 19 analyst firms have reported ratings in the last year.

康託·菲茨傑拉德於2023年7月21日報道了Aravive(納斯達克代碼：ARIV)的最新目標價。這家分析公司將目標價定為18美元，預計ARAV值將在12個月內上漲(可能上漲922.73%)。去年有19家分析公司公佈了評級。

What is the most recent analyst rating for Aravive (ARAV)?

分析師對Aravive(ARAV)的最新評級是多少？

The latest analyst rating for Aravive (NASDAQ: ARAV) was provided by Cantor Fitzgerald, and Aravive reiterated their overweight rating.

分析師對Aravive(納斯達克代碼：ARIV)的最新評級由康託·菲茨傑拉德提供，Aravive重申其增持評級。

When is the next analyst rating going to be posted or updated for Aravive (ARAV)?

Aravive(ARAV)的下一次分析師評級將於何時發佈或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aravive, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aravive was filed on July 21, 2023 so you should expect the next rating to be made available sometime around July 21, 2024.

分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Aravive的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Aravive的上一次評級是在2023年7月21日提交的，所以你應該預計下一次評級將在2024年7月21日左右提供。

Is the Analyst Rating Aravive (ARAV) correct?

分析師對Aravive(ARAV)的評級正確嗎？

While ratings are subjective and will change, the latest Aravive (ARAV) rating was a reiterated with a price target of $0.00 to $18.00. The current price Aravive (ARAV) is trading at is $1.76, which is within the analyst's predicted range.

雖然評級是主觀的，並將發生變化，但最新的Aravive(ARAV)評級被重申，目標價在0.00美元至18.00美元之間。Aravive(ARAV)目前的交易價格為1.76美元，在分析師的預測範圍內。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論